drugset / Trial / NCT07757087

A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo

NCT07757087 ↗

Phase 1 Recruiting 120 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to evaluate how NNC0487-0111 affects the amount of energy the body uses in people living with obesity or overweight following weight loss. This will be compared with the amount of energy used by participants who achieve weight loss through a low-calorie diet and by participants receiving placebo (without weight loss).

Timeline

Start
2026-08-03
Primary completion
2028-09-18
Completion
2028-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject NNC0487-0111 Unknown — Subcutaneous

Indications